Harvest Investment Services, LLC Gilead Sciences, Inc. Transaction History

Harvest Investment Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$57.92 - $72.58 $442,798 - $554,874	-7,645 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $115,356 - $130,931	-1,778 Reduced 18.87%	7,645 $555,000
Q3 2021 Oct 29, 2021	SELL	$67.69 - $73.03 $6,295 - $6,791	-93 Reduced 0.98%	9,423 $658,000
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $27,038 - $29,543	-426 Reduced 4.28%	9,516 $655,000
Q1 2021 May 06, 2021	SELL	$60.0 - $68.46 $258,180 - $294,583	-4,303 Reduced 30.21%	9,942 $642,000
Q4 2020 Feb 01, 2021	BUY	$56.65 - $64.55 $161,452 - $183,967	2,850 Added 25.01%	14,245 $829,000
Q3 2020 Oct 29, 2020	BUY	$62.1 - $78.08 $84,083 - $105,720	1,354 Added 13.48%	11,395 $720,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $286,611 - $332,808	3,962 Added 65.18%	10,041 $772,000
Q1 2020 Apr 21, 2020	BUY	$62.63 - $80.22 $380,727 - $487,657	6,079 New	6,079 $454,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Investment Services, LLC with notifications on news.